Results 111 to 120 of about 23,315 (198)

Pioglitazone mitigates early brain injury by suppressing neuroinflammation and oxidative stress after subarachnoid hemorrhage: a rodent model study. [PDF]

Ann Med
Cetinkaya K, Özates MÖ, Kullukçu H, Ünsal Y, Kazancı A, Gürcan O, Önder E, Deveci Bulut TS, Gürcay AG.   +8 more
europepmc   +1 more source

Targeting the PPAR-γ-ABC transporter axis ameliorates secondary pulmonary alveolar proteinosis induced by indium oxide nanoparticles. [PDF]

Part Fibre Toxicol
Jeon S, Kim G, Cho WS.
europepmc   +1 more source

Berberine and Metabolic Dysfunction‐Associated Steatotic Liver Disease: Hope or Hype?

Pharmacology Research &Perspectives, Volume 14, Issue 4, August 2026.
Ruth Nona, Eric Kalo
wiley   +1 more source

Pioglitazone

Reactions Weekly, 2015
Sanjay, Kalra, Yashdeep, Gupta
openaire   +3 more sources

Effect of Locally-Administered Pioglitazone on the Survival of Dermal Skin Flaps in an Experimental Study on Rats. [PDF]

Cureus
Basagiannis ED, Damaskos C, Garmpis N, Kykalos S, Papalampros A, Nikiteas N.   +5 more
europepmc   +1 more source

Tracking of Neuroinflammation Dynamics During Combined Anti-β-Amyloid Therapy (AAT) and Immunomodulation in a Preclinical Alzheimer's Disease Model. [PDF]

Int J Mol Sci
Wind-Mark K, Kunze LH, Willem M, Palumbo G, Giudici C, Nuscher B, Boening G, Gildehaus FJ, Lindner S, Werner RA, Franzmeier N, Gnörich JS, Brendel M, Zatcepin A.   +13 more
europepmc   +1 more source

Effects of PPARα, PPARγ, and dual PPARα/γ agonists on liver tissue and biochemical markers in NAFLD-induced Wistar rats. [PDF]

Res Pharm Sci
Khoshbakht E, Dinarvand N, Yaghooti H, Taheri B, Mohammadtaghvaei N.   +4 more
europepmc   +1 more source

Targeting Inflammation by Pioglitazone and its R-Enantiomer Mitigates Pathological Myocardial Remodeling in Murine Hypertrophic Cardiomyopathy. [PDF]

JACC Basic Transl Sci
Pfaller AT, Veneziano C, Murthi SR, Stöckl JB, Shashikadze B, Flenkenthaler F, Gorham J, Moretti A, Kitanovic A, Gearing LJ, Heinrich F, Durek P, Lehmann K, Mashreghi MF, Ewert P, Fröhlich T, Schmitt JP, Spielmann N, Hrabě de Angelis M, Schmid M, Toepfer CN, Latz E, Klingel K, Santamaria G, Seidman JG, Seidman CE, Wolf CM.   +26 more
europepmc   +1 more source

The Role of Antidiabetic Therapies in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review of Metformin, Pioglitazone, and GLP-1 Receptor Agonists. [PDF]

Int J Mol Sci
Mahoon DA, Hamad O, Butler AE.
europepmc   +1 more source

Differential Effects of Oral Antidiabetic Drugs on Skeletal Muscle Mass and Hemoglobin Levels in Adults with Type 2 Diabetes Mellitus: A Prospective Real-World Cohort Study. [PDF]

J Clin Med
Ziyadanoğlu FP, Çiftçi Öztürk E, Şengün G, Şahin Sİ, Aydın BÇ, Ataoğlu HE.   +5 more
europepmc   +1 more source